RICHELLE WORTHAM: Open Payments
NPI 1235891417 · SEARCY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 45 payments from 11 companies in 2025. Trend: 2023 $377 · 2024 $379 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $447 |
| AstraZeneca Pharmaceuticals LP | 6 | $86 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Alkermes, Inc. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Lundbeck LLC | 1 | $29 |
| Lilly USA, LLC | 1 | $22 |
| Verona Pharma, Inc. | 1 | $20 |
| Hologic Sales and Service, LLC | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, BREZTRI, TRELEGY ELLIPTA, VIVITROL, CAPLYTA, REXULTI, MOUNJARO, Ohtuvayre.
Industry payments across AR — which companies pay providers there.
